Search Results 1-10 of 4678 for ������������������������ ������������KaKaotalk:PC53���24������ ���������������
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to evaluate the safety and tolerability of ART24 after 7 or 28 days of daily administration in recently-cured C. diff infection ...
The purpose of this study is to evaluate changes in coagulation and antithrombosis factors in adult participants with PMM2-CDG after 24 weeks of dosing.
This study is being conducted to examine survival, safety, and the magnitude of the immune response induced following administration of DN24-02 in subjects with ...
unexplained cough for which an underlying condition has not been determined despite adequate investigation with diagnostic tests and trials of therapy.
Medicines such as antidepressants and anti-anxiety drugs may be used with talk therapy to help with symptoms of depression and anxiety. As with therapy, you may ...
... 24-hour cough frequency in an enriched population of adults with refractory chronic cough (including unexplained chronic cough) at 24 weeks. Participation ...
Talk to your health care provider about your specific needs. Adult vaccines to consider include: COVID-19. The coronavirus disease 2019 (COVID-19) vaccine might ...
Find clinical trials and clinical studies at Mayo Clinic, and learn about clinical research and reasons to volunteer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.